Seminars in Nuclear Medicine
Volume 31, Issue 2 , Pages 165-167 , April 2001

The evolution of cerebral perfusion abnormalities in lewy body disease: Assessment with Tc-99m hexamethylpropylene amineoxime single photon emission computed tomography

    MD
  • Mordechai Lorberboym

      Affiliations

    • Department of Nuclear Medicine of The Edith Wolfson Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    • Department of Neurology of The Edith Wolfson Medican Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    • Corresponding Author InformationAddress reprint requests to Mordechai Lorberboym, MD, Department of Nuclear Medicine, The Edith Wolfson Medical Center, Holon, 58100 Israel.
    • ,
  • Yair Lampl

      Affiliations

    • Department of Nuclear Medicine of The Edith Wolfson Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    • Department of Neurology of The Edith Wolfson Medican Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    • ,
  • Robert C. Stadalnik

References 

  1. Varma AR, Talbot PR, Snowden JS, et al. A 99mTc-HMPAO single-photon emission computed tomography study of Lewy body disease. J Neurol. 1997;244:349–359
  2. Sawada H, Udaka F, Kameyama M, et al. SPECT findings in Parkinson's disease associated with dementia. J Neurol Neurosurg Psychiatry. 1992;55:960–963
  3. Talbot PR, Lloyd JJ, Snowden JS, et al. A clinical role for 99mTc-HMPAO SPECT in the investigation of dementia?. J Neurol Neurosurg Psychiatry. 1998;64:306–313
  4. Read SL, Miller BL, Mena ITI, et al. SPECT in dementia: Clinical and pathological correlation. J Am Geriatr Soc. 1995;43:1243–1247
  5. Aharon Peretz J, Israel O, Goldsher D, et al. Posterior cortical atrophy variants of Alzheimer's disease. Dement Geriatr Cogn Disord. 1999;10:483–487
  6. Weinstein HC, Haan J, van Royen EO. SPECT in the diagnosis of Alzheimer's disease and multi-infarct-dementia. Clin Neurol Neurosurg. 1991;93:39–43
  7. Otte A, Ettlin TM, Nitzsche EU, et al. PET and SPECT in whiplash syndrome: A new approach to a forgotten brain?. J Neurol Neurosurg Psychiatry. 1997;63:368–372
  8. Otte A, Ettlin TM, Fierz L, et al. Cerebral findings following cervical spine distortion caused by acceleration mechanism (whiplash injury). Assessment of current diagnostic methods in nuclear medicine. Schweiz Rundsch Med Prax. 1996;85:1087–1090
  9. Torigoe R, Hayashi T, Anegawa S, et al. Evaluation of SPECT with N-isopropyl [I-123]-p-iodoamphetamine (IMP) or technetium-99m [99mTc]-d,1-hexamethylpropyleneamine oxime (d,1-HM-PAO) in cerebral concussion. No To Shinkei. 1991;43:530–535
  10. Jaracz J, Rajewski A, Junik R, et al. The assessment of regional cerebral blood flow using HMPAO-SPECT during depressive episode and in remission. Psychiatr Pol. 1996;30:757–769
  11. Sayit E, Dirik E, Durak H, et al. Landau-Kleffner syndrome: Relation of clinical. EEG and Tc-99m-HMPAO brain SPECT findings and improvement in EEG after treatment. Ann Nucl Med. 1999;13:415–418
  12. Oshima M, Kikuchi Y, Furui S. Cerebral perfusion impairment with normal magnetic resonance imaging findings in a patient with neuro-Behçet's disease. Clin Nucl Med. 2000;25:156–157
  13. Denays R, Tondeur M, Foulon MTI. Regional brain blood flow in congenital dysphasia: Studies with technetium-99m HM-PAO SPECT. J Nucl Med. 1989;30:1825–1829
  14. Cohen D, Krausz Y, Lossos A. Brain SPECT imaging with Tc-99m HM-PAO in Creutzfeldt-Jakob disease. Clin Nucl Med. 1989;14:808–810
  15. Satoh M, Ishikawa N, Yoshizawa T, et al. N-isopropyl-p-[123I]iodoamphetamine SPECT in MELAS syndrome: Comparison with CT and MR imaging. J Comput Assist Tomogr. 1991;15:77–82
  16. Liewendahl K, Vanhanen SL, Heiskala H, et al. Brain perfusion SPECT abnormalities in neuronal ceroid lipofuscinoses. Neuropediatrics. 1997;28:71–73
  17. Riikonen R, Salonen I, Partanen K, et al. Brain perfusion SPECT and MRI in foetal alcohol syndrome. Dev Med Child Neurol. 1999;41:652–659

PII: S0001-2998(01)80044-1

doi: 10.1053/snuc.2001.21487

Seminars in Nuclear Medicine
Volume 31, Issue 2 , Pages 165-167 , April 2001

Article Tools